Email LinkedIn Twitter

Metric-Based Presentations

These online survey-based studies are ideal for learning what other companies are doing, how they measure what they do, what resources they devote to activities, what they find effective, and other insights. These are useful for doing a gap analysis.

Show details for Brand Management and Product LeadershipBrand Management and Product Leadership
Show details for Business CommunicationsBusiness Communications
Show details for Business OperationsBusiness Operations
Show details for Clinical OperationsClinical Operations
Show details for Competitive and Business IntelligenceCompetitive and Business Intelligence
Show details for Customer ServiceCustomer Service
Show details for GBC ConferencesGBC Conferences
Show details for Human ResourcesHuman Resources
Show details for IndustryIndustry
Show details for InternetInternet
Show details for Knowledge ManagementKnowledge Management
Show details for Managed CareManaged Care
Show details for Market Research, Analytics and ForecastingMarket Research, Analytics and Forecasting
Show details for Marketing ManagementMarketing Management
Show details for Medical AffairsMedical Affairs
Show details for MembershipsMemberships
Hide details for New Product DevelopmentNew Product Development
Gene Maps: DNA Technology Survey Analysis This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.
This 39-slide presentation includes findings and forecasting on gene maps and DNA technology... (ID 4510)
Companies Profiled: Boehringer-Ingelheim, Vysis, Stratagene, Celera, more ...
Price: $891.95


Report Summary -- Bolstering Product Portfolios: Resources, Structure and Process for Effective In-licensing Organizations 
Gain insight into how to structure in-licensing organizations, develop processes that facilitate the ability to identify the best opportunities and move smoothly from initial contact to binding agreement... (ID OP-93A)
Companies Profiled: AstraZeneca, Sanofi-aventis, Bristol-Myers Squibb, Genentech, more ...
Price: $0.00


Bolstering Product Portfolios: Resources, Structure and Process for Effective In-licensing Organizations 
Gain insight into how to structure in-licensing organizations, develop processes that facilitate the ability to identify the best opportunities and move smoothly from initial contact to binding agreement... (ID OP-93)
Companies Profiled: AstraZeneca, Sanofi-aventis, Bristol-Myers Squibb, Genentech, more ...
Price: $3328.00


Profiles of In-Licensing Organizations 2 This document contains Graphics, a detailed Process Map and a practice summary Matrix.This document contains Graphics, a detailed Process Map and a practice summary Matrix.This document contains Graphics, a detailed Process Map and a practice summary Matrix.
This 16-page document profiles in-licensing organizations at five leading pharmaceutical companies... (ID 4496)
Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ...
Price: $505.95


Profiles of In-Licensing Organizations 1 This document contains Graphics, a detailed Process Map and a practice summary Matrix.This document contains Graphics, a detailed Process Map and a practice summary Matrix.This document contains Graphics, a detailed Process Map and a practice summary Matrix.
This 13-page document profiles in-licensing organizations at four leading pharmaceutical companies... (ID 4495)
Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ...
Price: $482.95


Winning In-Licensing Strategies in Developing Criteria for Compound Evaluations This document contains Graphics.
This nine-page document examines three critical approaches to developing strategy for in-licensing organizations... (ID 4497)
Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ...
Price: $436.95


In-Licensing Organization Structure This document contains Metrics and Graphics.This document contains Metrics and Graphics.
This 19-page document examines key elements that determine the structure of high-performing in-licensing operations... (ID 4498)
Companies Profiled: AstraZeneca, Sanofi-aventis, Bristol-Myers Squibb, GlaxoSmithKline, more ...
Price: $574.95


In-Licensing Process: Steps to Accelerate Assessment and Agreement This document contains Metrics and Graphics.This document contains Metrics and Graphics.
This 22-page document examines key processes that drive high-performing in-licensing operations... (ID 4499)
Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ...
Price: $574.95


Top Factors for Effective In-Licensing Organizations This document contains Graphics and a practice summary Matrix.This document contains Graphics and a practice summary Matrix.
This 11-page document provides a comprehensive overview of of insights and recommendations for building and managing an effective product in-licensing organization based on in-depth interviews with business development leaders from top pharmaceutical companies... (ID 4494)
Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Johnson & Johnson, more ...
Price: $410.00


Portfolio Development, Management & Measurement This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Leading companies invest considerable staff, time, resources and share of mind in the area of portfolio development, management and measurement... (ID 4317)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $1249.95


Managing Processes, Tools and Techniques This document contains Graphics.
When it comes to managing the tools and processes of early-stage marketers, benchmark partners stress the importance of executing fundamentals: managing processes, managing across functions, working effectively among teams and departments, and conducting effective market research that will yield insights and pathways to commercial success... (ID 4316)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $1449.95


Developing "Soft and Hard Skills" to Increase Commercialization Effectiveness This document contains Graphics.
Soft skills and interpersonal characteristics are often the main differentiation between a successful commercialization employee and one who is less influential... (ID 4315)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $516.95


Optimizing Process Integration Through Structure and Resources This document contains Metrics and Graphics.This document contains Metrics and Graphics.
Portfolio management and, especially, commercialization functions are becoming more critical to company bottom-line performance as a result of numerous internal and external factors, including weak drug pipelines and intensive pharmaceutical competition... (ID 4314)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $1099.95


Early Stage Product Commercialization: Summary and Lessons Learned This document contains Graphics.
Since the percentage of successful compounds is so small and the development cycle so long, leading pharmaceutical companies strive to allocate resources to compounds with the greatest potential market value, and they begin investing marketing dollars in those drugs early in the development process... (ID 4312)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $824.95


Report Summary -- From Genes to Giants: Best Practices in Early-Stage Product Commercialization 
To download this excerpt, click "Download FREE Excerpt"... (ID SM-162A)
Companies Profiled: Abbott, Allergan, Bayer, Boehringer-Ingelheim, more ...
Price: $0.00


From Genes to Giants: Best Practices in Early-Stage Product Commercialization 
Long and costly product development cycles make it essential today for pharmaceutical companies to allocate resources to the development of compounds with the greatest potential market value... (ID SM-162)
Companies Profiled: Abbott, Allergan, Bayer, Boehringer-Ingelheim, more ...
Price: $5058.00


The Increasing Role of Marketing in New Drug Development: Winning Through Commercially-Focused Drug Development This document contains Graphics.
Best Practices, LLC’s research team has performed a benchmark review on this important issue for member companies of the Sales and Marketing Excellence Forum... (ID 4060)
Companies Profiled: Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Glaxo Wellcome, more ...
Price: $74.95


Show details for Patient Focused ServicesPatient Focused Services
Show details for Product LaunchProduct Launch
Show details for Quality, Compliance and RegulatoryQuality, Compliance and Regulatory
Show details for R and AS ConferencesR and AS Conferences
Show details for Sales and MarketingSales and Marketing
Show details for Sales LeadershipSales Leadership
Show details for Samples and Free ReportsSamples and Free Reports
Show details for (Not Categorized)(Not Categorized)

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information